These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 17547042

  • 1. Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.
    Mizuno Y, Kudo K, Kano S.
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():11-4. PubMed ID: 17547042
    [Abstract] [Full Text] [Related]

  • 2. Knowledge, attitudes, and practices of Japanese travelers towards malaria prevention during overseas travel.
    Namikawa K, Kikuchi H, Kato S, Takizawa Y, Konta A, Iida T, Kimura M.
    Travel Med Infect Dis; 2008 May; 6(3):137-41. PubMed ID: 18486069
    [Abstract] [Full Text] [Related]

  • 3. Malaria prevention and stand-by emergency treatment among Japanese travelers.
    Kimura M, Kawakami K, Hashimoto M, Hamada M.
    Travel Med Infect Dis; 2006 Mar; 4(2):81-5. PubMed ID: 16887729
    [Abstract] [Full Text] [Related]

  • 4. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N, D'Acremont V, Landry P, Genton B.
    Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
    [Abstract] [Full Text] [Related]

  • 5. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand.
    Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stüben U, Schönfeld C, Stark K.
    J Travel Med; 2008 Dec; 15(3):162-71. PubMed ID: 18494693
    [Abstract] [Full Text] [Related]

  • 6. Malaria chemoprophylaxis advice: survey of South African community pharmacists' knowledge and practices.
    Toovey S.
    J Travel Med; 2006 Dec; 13(3):161-5. PubMed ID: 16706947
    [Abstract] [Full Text] [Related]

  • 7. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team.
    Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574
    [Abstract] [Full Text] [Related]

  • 8. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
    Matsumura T, Fujii T, Miura T, Koibuchi T, Endo T, Nakamura H, Odawara T, Iwamoto A, Nakamura T.
    J Infect Chemother; 2005 Aug 01; 11(4):196-8. PubMed ID: 16133712
    [Abstract] [Full Text] [Related]

  • 9. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T, Okuda J, Ide D, Amano K, Takei Y, Yamaguchi Y.
    J Infect Chemother; 2013 Feb 01; 19(1):20-3. PubMed ID: 22740189
    [Abstract] [Full Text] [Related]

  • 10. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
    Lopez-Velez R, Bayas JM.
    J Travel Med; 2007 Feb 01; 14(5):297-305. PubMed ID: 17883460
    [Abstract] [Full Text] [Related]

  • 11. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ, Koene HR, Spong K, Overbosch D.
    J Travel Med; 2007 Feb 01; 14(2):92-5. PubMed ID: 17367478
    [Abstract] [Full Text] [Related]

  • 12. Inadequate chemoprophylaxis and the risk of malaria.
    Massey P, Durrheim DN, Speare R.
    Aust Fam Physician; 2007 Dec 01; 36(12):1058-60. PubMed ID: 18075636
    [Abstract] [Full Text] [Related]

  • 13. Controversies and misconceptions in malaria chemoprophylaxis for travelers.
    Chen LH, Wilson ME, Schlagenhauf P.
    JAMA; 2007 May 23; 297(20):2251-63. PubMed ID: 17519415
    [Abstract] [Full Text] [Related]

  • 14. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B, Péguet C, Nevez G.
    Bull Soc Pathol Exot; 1997 May 23; 90(4):273-6. PubMed ID: 9479468
    [Abstract] [Full Text] [Related]

  • 15. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA, Bosje T, Luinstra-Passchier MJ.
    Ned Tijdschr Geneeskd; 1997 Feb 15; 141(7):331-4. PubMed ID: 9132607
    [Abstract] [Full Text] [Related]

  • 16. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E, Regev-Yochay G.
    Clin Infect Dis; 1999 Dec 15; 29(6):1502-6. PubMed ID: 10585803
    [Abstract] [Full Text] [Related]

  • 17. Clinical practice. Malaria prevention in short-term travelers.
    Freedman DO.
    N Engl J Med; 2008 Aug 07; 359(6):603-12. PubMed ID: 18687641
    [No Abstract] [Full Text] [Related]

  • 18. Plasmodium falciparum malaria associated with mefloquine failure in Gambia.
    Callen EC, Church CO.
    Pharmacotherapy; 2006 Oct 07; 26(10):1526-8. PubMed ID: 16999663
    [Abstract] [Full Text] [Related]

  • 19. Travel-related health problems in Japanese travelers.
    Mizuno Y, Kudo K.
    Travel Med Infect Dis; 2009 Sep 07; 7(5):296-300. PubMed ID: 19747665
    [Abstract] [Full Text] [Related]

  • 20. Mefloquine for preventing malaria in nonimmune adult travelers.
    Cayley WE.
    Am Fam Physician; 2004 Feb 01; 69(3):521-2. PubMed ID: 14971832
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.